| |
|
|
|
ImmunoGen Inc.  
|
|
2.57 0.11 (0.04%) |
03-21 16:00 |
|
Open: |
2.46 |
Pre close: |
2.46 |
Target:
|
5.44
|
|
High: |
2.59 |
Low: |
2.41 |
Resistance:
|
4.66
6.13
|
|
Volume: |
3,388,922 |
Market Cap: |
384M |
Support:
|
2.27
1.89
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.56
 |
MACD |
MACD(12,26):
|
-0.64  |
|
MA(20): |
3.30 |
Signal(12,26,9): |
-0.64 |
|
MA(100): |
4.91 |
Stochastic Oscillator |
%K(14,3):
|
20.07 |
|
MA(250): |
7.88 |
%D(3): |
12.17 |
|
Average Volume(K) |
3-Month: |
377322
|
52-Week |
High:
|
13.41 |
|
10-Days: |
360289 |
Low: |
2.27 |
|
RSI |
RSI(14):
|
29.92 |
Change(%): |
-78.9 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.190 |
Return on Equity (ttm) |
4877.7 |
Shares Out. (M) |
149.41 |
|
EPS Est. Current Year |
-0.720 |
Return on Assets (ttm) |
-57.2 |
Shares Float (M) |
147.13 |
|
EPS Est. Next Year |
-1.380 |
PEG Ratio |
0.00 |
% Held by Insiders |
1.70 |
|
EPS Est. Next Quarter |
-0.240 |
Qtrly Rev. Growth |
-66.0 |
% Held by Institutions |
115.20 |
|
Forward EPS |
-0.950 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
36.770 |
EBITDA (p.s.) |
0.000 |
P/E |
-2.16 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.07 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-166.42 |
P/S |
1010483392.00 |
|
Operating Margin |
-295.17 |
Levered Free Cash Flow
(M) |
-78.73 |
P/CF |
-2.31 |
|
|
|
|
|
|
